Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes

Acta Haematol. 1988;79(1):1-6. doi: 10.1159/000205681.

Abstract

Megakaryocytopoiesis in polycythemia vera (PV) was characterized by in vitro growth of marrow megakaryocytic progenitors (CFU-Meg) and quantitation of megakaryocyte numbers in marrow biopsy specimens in 14 patients with PV. Megakaryocyte numbers and CFU-Meg numbers in the 14 patients were variable, with values from the control range to markedly increased numbers. Nine of the 14 patients showed spontaneous CFU-Meg growth, and the presence or absence of spontaneous CFU-Meg growth was found to be related to the degree of marrow megakaryocyte increase, i.e., those with spontaneous CFU-Meg had higher megakaryocyte numbers. None of the plasmas from the PV patients contained detectable levels of megakaryocyte colony-stimulating activity (Meg-CSA), assayed using the culture with nonadherent normal marrow cells and tested plasma without phytohemagglutinin-stimulated leukocyte-conditioned medium as an exogenous source of Meg-CSA. Increased megakaryocyte numbers and resultant thrombocytosis in PV are likely based on the abnormal population of CFU-Meg.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Cell Count
  • Bone Marrow / pathology*
  • Colony-Forming Units Assay
  • Colony-Stimulating Factors / blood
  • Female
  • Hematopoiesis
  • Hematopoietic Stem Cells / pathology*
  • Humans
  • Male
  • Megakaryocytes / pathology*
  • Middle Aged
  • Polycythemia Vera / blood*
  • Polycythemia Vera / pathology
  • Thrombocythemia, Essential / blood
  • Thrombocythemia, Essential / pathology

Substances

  • Colony-Stimulating Factors